King Pharmaceuticals Inc Stock Overlap Studies Parabolic SAR

KG Stock   26.76  0.04  0.15%   
KING PHARMACEUTICALS overlap studies tool provides the execution environment for running the Parabolic SAR study and other technical functions against KING PHARMACEUTICALS. KING PHARMACEUTICALS value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of overlap studies indicators. As with most other technical indicators, the Parabolic SAR study function is designed to identify and follow existing trends. KING PHARMACEUTICALS overlay technical analysis usually involve calculating upper and lower limits of price movements based on various statistical techniques. Please specify Acceleration Factor and AF Maximum to execute this module.

The output start index for this execution was one with a total number of output elements of sixty. The Parabolic SAR indicator is used to determine the direction of KING PHARMACEUTICALS INC's momentum and the point in time when KING PHARMACEUTICALS has higher than normal probability directional change.

KING PHARMACEUTICALS Technical Analysis Modules

Most technical analysis of KING PHARMACEUTICALS help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for KING from various momentum indicators to cycle indicators. When you analyze KING charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About KING PHARMACEUTICALS Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of KING PHARMACEUTICALS INC. We use our internally-developed statistical techniques to arrive at the intrinsic value of KING PHARMACEUTICALS INC based on widely used predictive technical indicators. In general, we focus on analyzing KING Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build KING PHARMACEUTICALS's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of KING PHARMACEUTICALS's intrinsic value. In addition to deriving basic predictive indicators for KING PHARMACEUTICALS, we also check how macroeconomic factors affect KING PHARMACEUTICALS price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2024 2025 (projected)
Days Sales Outstanding9.638.56
PTB Ratio3.043.19
Hype
Prediction
LowEstimatedHigh
24.1426.8329.52
Details
Intrinsic
Valuation
LowRealHigh
19.6322.3229.50
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as KING PHARMACEUTICALS. Your research has to be compared to or analyzed against KING PHARMACEUTICALS's peers to derive any actionable benefits. When done correctly, KING PHARMACEUTICALS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in KING PHARMACEUTICALS INC.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards KING PHARMACEUTICALS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, KING PHARMACEUTICALS's short interest history, or implied volatility extrapolated from KING PHARMACEUTICALS options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 90 shares
Utilities Idea
Utilities
Invested over 90 shares
Power Assets Idea
Power Assets
Invested over 90 shares
Basic Utilities Idea
Basic Utilities
Invested over 90 shares
Gold and Gold Mining Idea
Gold and Gold Mining
Invested few shares
Precious Metals Idea
Precious Metals
Invested few shares
Steel Works Etc Idea
Steel Works Etc
Invested few shares
Healthcare Idea
Healthcare
Invested few shares
Obamacare Idea
Obamacare
Invested few shares
Chemicals Idea
Chemicals
Invested few shares
Semiconductor Idea
Semiconductor
Invested few shares
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in KING PHARMACEUTICALS INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of KING PHARMACEUTICALS. If investors know KING will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about KING PHARMACEUTICALS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
9.21
Revenue Per Share
1.289
Quarterly Revenue Growth
7.803
The market value of KING PHARMACEUTICALS INC is measured differently than its book value, which is the value of KING that is recorded on the company's balance sheet. Investors also form their own opinion of KING PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is KING PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because KING PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect KING PHARMACEUTICALS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between KING PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine if KING PHARMACEUTICALS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, KING PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.